{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

IBC Connect Community: A Coalition to Advance and Optimize Guideline-Concordant Care and Research


LIVE
IBC Connect Community: A Coalition to Advance and Optimize Guideline-Concordant Care and Research Banner

  • Overview
  • Faculty
  • Schedule
  • Hotel
  • Exhibitors
  • Register
Add to Calendar IBC Connect Community: A Coalition to Advance and Optimize Guideline-Concordant Care and Research 11/13/2025 6:30:00 PM 11/14/2025 7:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/IBCCC2025 Description: Inflammatory breast cancer (IBC) is a rare and highly aggressive form of breast cancer with a significantly poorer prognosis compared to other subtypes, due to its rapid progression, high risk of metastasis and relapse, and elevated mortality rate. Despite numerous efforts, no FDA-approved, IBC-specific therapies or diagnostic tools currently exist. As such, there is an urgent need to identify effective therapeutic str... MD Anderson - Duncan Building false MM/DD/YYYY


Date & Location
Thursday, November 13, 2025, 6:30 PM - Friday, November 14, 2025, 7:00 PM, MD Anderson - Duncan Building, Houston, TX

Target Audience
Specialties - ALL
Professions - Nurse - APRN, Nurse - LVN, Nurse - RN, Other, Physician (MD or DO), Physician Associate, Student or Trainee

Credits
AMA PRA Category 1 Credits™ (43.50 hours), Non-Physician Attendance (43.50 hours)

Overview
Inflammatory breast cancer (IBC) is a rare and highly aggressive form of breast cancer with a significantly poorer prognosis compared to other subtypes, due to its rapid progression, high risk of metastasis and relapse, and elevated mortality rate. Despite numerous efforts, no FDA-approved, IBC-specific therapies or diagnostic tools currently exist. As such, there is an urgent need to identify effective therapeutic strategies that can improve patient survival. This two-day meeting will bring together clinical investigators, practicing physicians, basic scientists, patient advocates, and institutions interested in establishing IBC clinics in their regions. The goal is to advance understanding of the disease, promote collaboration, enhance guideline-concordant care, and design community-based trials or data initiatives that directly benefit IBC patients. We anticipate that the insights and partnerships formed during this meeting will lead to measurable improvements in outcomes such as survival and tumor response within the next three years.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Review the current standards of care for diagnosis and treatment of inflammatory breast cancer (IBC), including trends in the decreasing use of some standard approaches.
  2. Discuss ongoing clinical trials in IBC and novel breast cancer treatments, covering both biological insights and operational strategies to foster expanded collaboration across the US.
  3. Examine new concepts from the latest translational research developments related to IBC.
  4. Initiate strategies to translate basic research findings into clinical research or direct patient care.

Registration

The IBC Connect Community: A Coalition to Advance and Optimize Guideline-Concordant Care and Research will begin on Thursday, November 13, 2025, with a Poster Session and Networking Event featuring light refreshments from 6:30 PM to 9:00 PM. The conference will continue on Friday, November 14, 2025, Opening Remarks at 8:00 AM and will adjourn at 5:00 PM. This conference will be held at the Duncan Building (CPB) ,1155 Pressler St., 8th Floor (rooms 1-8), Houston, TX 77030.

 

CONFERENCE REGISTRATION FEES:

 

Physicians (MD, DO’s) – In Person

$50

Students/Fellows/Residents/All Others – In Person

$25

 

 

Physicians (MD, DO’s) - Virtual

$50

Students/Fellows/Residents/All Others – Virtual

$25

 

 

We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)

  • Check (payable to The University of Texas MD Anderson Cancer Center through U.S. banks only)

 

Mail checks to:

     Continuing Professional Education – Unit 1781
     The University of Texas MD Anderson Cancer Center
     P.O. Box 301407
     Houston, TX 77230-1407

Telephone registrations will not be accepted.

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.  Once your payment has been made, a receipt can be found in the MyCE tab of your PEP@MD Anderson account. 

Refund/Cancellation Policy
The registration fee, minus a $25.00 administration-handling fee, is refundable if a written request is 
received on or before Friday, November 7, 2025.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the Department of Continuing Professional Education, is limited to the registration fee. CPE will refund the full registration fee. 
 
The Department of Continuing Professional Education, reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

Special Assistance

For additional information contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]. If you have any ADA accommodation needs or need assistance.

 

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. The survey link will be provided during the review course.


Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 


Hotel Options: 

Houston Marriott Medical Center / Museum District
6580 Fannin Street
Houston TX  7030
713-770-8167
Houston Marriott Medical Center / Museum District
Room Rate: Varies

Hilton Houston Plaza/Medical Center
6633 Travis Street
Houston TX  7030
713-313-4000
Hilton Houston Plaza/Medical Center
Room Rate: Varies

DoubleTree by Hilton Houston Medical Center Hotel & Suites
6800 Main Street
Houston, TX  77030
713-528-7744
DoubleTree by Hilton Medical Center
Rom Rate: Varies

Hilton Garden Inn Houston Medical Center
6840 Almeda Rd.
Houston, Texas 77030
346-433-8200
Hilton Garden Inn Houston Medical Center
Rom Rate: Varies

 



The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Mitigation of Relevant Financial Relationships


The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Wendy A. Woodward, MD
Professor, Radiation Oncology Department
The University of Texas MD Anderson Cancer Center
Course Director, Faculty
Nothing to disclose
Terry Arnold
Founder
IBC Network Foundation
Faculty
Yee Chung Cheng, MD
Associate Professor
Medical College of Wisconsin
Faculty
Rachel Ford
Patient
Patient
Faculty
Chelain R. Goodman, MD
Assistant Professor
UT MD Anderson Cancer Center
Faculty
Angelica Lim, BSN
MD Anderson
Faculty
Anthony Lucci, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Ginny Mason, BSN
Executive Director
Inflammatory Breast Cancer Research Foundation
Faculty
Mark Schaverien, MD
Assistant Professor
MD Anderson Cancer Center
Faculty
Jasmine S. Sukumar, MD
University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Susie X. Sun, MD
UT MD Anderson
Faculty
Mediget Teshome, MD
Associate Professor, Breast Surgical Oncology
MD Anderson Cancer Center
Faculty
Angela Alexander, PhD
Senior Clinical Studies Coordinator
MD Anderson Cancer Center
Faculty, Other Planning Committee Member
Grant or research support-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Grant or research support-Daiichi Sankyo, Inc. (Relationship has ended)|Grant or research support-Genentech, Inc. (Relationship has ended)
Zeynep Aydi, MD
Banner MD Anderson
Faculty, Other Planning Committee Member
Nothing to disclose
Shakeela Bahadur, MD
Mayo Clinic
Faculty, Other Planning Committee Member
Nothing to disclose
Julia Laursen, BSN
None
Faculty, Other Planning Committee Member
Nothing to disclose
Rachel M. Layman, MD
Professor
MD Anderson Cancer Center
Faculty, Other Planning Committee Member
Grant or research support-Lilly USA, LLC|Grant or research support-Accutar Biotechnology, Inc.|Paid consultant-Lilly USA, LLC (Relationship has ended)|Grant or research support-Novartis Pharmaceuticals Corporation|Paid consultant-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Pfizer Inc.|Grant or research support-Puma|Grant or research support-Celcuity|Paid consultant-Celcuity (Relationship has ended)|Grant or research support-Arvinas|Grant or research support-Biotheryx|Paid consultant-Biotheryx (Relationship has ended)
Ashley Marumoto , MD
Surgeon
University of Hawaii
Faculty, Other Planning Committee Member
Nothing to disclose
Sadia Saleem, MD
Dr.
MD Anderson
Faculty, Other Planning Committee Member
Nothing to disclose
Michael C. Stauder, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty, Other Planning Committee Member
Nothing to disclose
Audree Tadros, MD, MPH
Associate Attending
Memorial Sloan Kettering Cancer Center
Faculty, Other Planning Committee Member
Nothing to disclose
Liz Beal, MEd
None
Other Planning Committee Member
Nothing to disclose
Swetha Bopparaju, MD, MBA
Program Director
MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Azadeh Nasrazadani, MD
MD Anderson Cancer Center
Other Planning Committee Member
Honoraria-Novartis Pharmaceuticals Corporation (Relationship has ended)|Consulting Fee-AstraZeneca US (Relationship has ended)
Marcella Sanchez, AA
Program Coordinator
MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Naoto T Ueno, MD, PhD
Director
University of Hawai?i Cancer Center
Other Planning Committee Member
Paid consultant-AstraZeneca US|Paid consultant-Bayer HealthCare Pharmaceuticals, Inc.|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Eisai, Inc.|Paid consultant-Genentech, Inc.|Paid consultant-Genomic Health, Inc.|Paid consultant-Gilead Sciences, Inc.|Paid consultant-Lavender Health, OncoCyte Corporation, Pear Bio, Peptilogics, Inc., Phoenix Molecular Designs,|Speakers Bureau-AstraZeneca US|Speakers Bureau-Daiichi Sankyo, Inc.|Speakers Bureau-Pfizer Inc.|Speakers Bureau-Chugai Roche, Inc.,Kyowa Kirin Co., Ltd., Total Health Conferencing, and Eli Lilly. |Grant or research support-Eisai, Inc.|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Phoenix Mole, Puma Biotech, Oncolys BioPharma, OBI, ChemDiv, Tolero Pharma,VITRAC Therapeutics
Martha L Van Dam, MS, LMHC, NCC
Living Beyond
Other Planning Committee Member
Nothing to disclose
Gary J Whitman, MD
Professor, Breast Imaging Department
The University of Texas MD Anderson Cancer Center
Other Planning Committee Member
Consulting Fee-Siemens Healthineers

Thursday, November 13, 2025
Poster Session, Networking, and Reception
6:30PM - 9:00PM
Friday, November 14, 2025
Breakfast and Registration
7:00AM - 8:00AM
 
Session 1: Guideline Concordant Care (GCC)

Moderator(s): Shakeela Bahadur, MD
Welcome Remarks
8:00AM - 8:15AM
Wendy A. Woodward, MD

IBC Guideline Concordant Care, NCBD
8:15AM - 8:30AM
Audree Tadros, MD, MPH

IBC Guideline Concordant Care, SEER
8:30AM - 8:45AM

Surgeon Guideline Self-Reporting
8:45AM - 9:00AM
Mediget Teshome, MD

Panel Discussion
9:00AM - 9:30AM
Rachel Ford
Julia Laursen, BSN

 
Session 2: Evidence & Gaps in IBC Diagnosis and Treatment

Moderator(s): Virginia Kaklamani, MD and Zeynep Aydi, MD
IBC Diagnosis Progress; IBC Score
9:30AM - 9:45AM
Ginny Mason, BSN

Surgery in IBC, always MRM?
9:45AM - 10:00AM

Axillary Procedures in IBC, always AxLND?
10:00AM - 10:15AM
Ashley Marumoto , MD

Radiation in IBC, Are There Options?
10:15AM - 10:30AM
Michael C. Stauder, MD

Break
10:30AM - 10:45AM

Preventing Lymphedema in IBC
10:45AM - 11:00AM
Mark Schaverien, MD

Grey Zones in Medical Oncology
11:00AM - 11:15AM

CASES:
11:15AM - 11:45AM
Yee Chung Cheng, MD
Sadia Saleem, MD
Susie X. Sun, MD


  • Stage IV Management Cases Surgery in stage IV (HER2 de novo)
  • Recurrent Disease; Reirradiation
  • Stage IV CAM
  • Poor Response Chemo

 
Session 3: Opportunities in Surveillance

Moderator(s): Massimo Cristofanilli, MD
Minimal Residual Disease in IBC
11:45AM - 12:00PM
Anthony Lucci, MD

Minimal Residual Disease in IBC
12:00PM - 12:15PM
Audree Tadros, MD, MPH

GLP-1 Inhibitors for Lymphedema
12:15PM - 12:30PM

Lunch - Consensus Update: Patient Education Session
12:30PM - 1:30PM

 
Session 4: Patient Perspectives & Advocacy Opportunities; Considerations for Community Outreach and Rural Practice

Moderator(s): Julia Laursen, RN
Advocate Training Initiatives - Concrete Ways to Get Involved
1:30PM - 1:45PM

Discussion
1:45PM - 2:15PM

 
Session 5: Building a National IBC Community Trialist Program

Moderator(s): Filipa Lynce, MD and Wendy Woodward, MD
IBC Connect and IBC CLEAR Project Overview
2:15PM - 2:30PM
Sadia Saleem, MD

IBC Clear Data Collection & Workflow
2:30PM - 2:45PM
Angela Alexander, PhD

AI in IBC
2:45PM - 3:00PM
Chelain R. Goodman, MD

Break
3:00PM - 3:15PM

Pragmatic Trials (TAD, RT Practices, LVB, ctDNA Timing, Stage IV)
3:15PM - 3:30PM
Rachel M. Layman, MD
Anthony Lucci, MD
Audree Tadros, MD, MPH

Small Group Breakout Sessions and Discussion
3:30PM - 4:00PM

IBCCC Planning:
4:00PM - 5:00PM
Terry Arnold
Wendy A. Woodward, MD


  • Opportunities in Community Engagement; Reaching Rural Providers
  • Role of Advocacy
  • Funding Opportunities & Next Steps
  • Governance Models (e.g., TBCRC) -TBCRC or NRG models? Authorship & Credit Guidelines (e.g., NRG) 

Adjourn - Reception & Informal Networking
5:00PM - 5:05PM

Exhibitor Registration Coming Soon

Exhibitor Registration Requirements

  • Registration & Agreement: To participate as an exhibitor, both registration and a signed exhibit agreement are required.

  • Confirmation Process: Your exhibit is only confirmed after completing registration and submitting a fully executed agreement.

  • Payment Timeline: The signed agreement and payment must be submitted prior to the event.

  • Additional Badges: Extra exhibitor badges can only be purchased by companies with confirmed exhibitor status.

  • Support Clarification: Grant and in-kind support are independent and separate from exhibitor fees.


Contact Us:
Robyn P. Davis, MPH, Senior Continuing Education Coordinator, Continuing Education
Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
PO Box 301407
Houston, TX 77230-1407
Phone: 346-721-9712
Email: [email protected]


W9 Form

Exhibitor Packages

Exhibitor Package - Bronze Level Price: $2500.00
Includes:
  • Recognition as a Bronze Level Exhibitor
  • 6ft. Tabletop Display (Draped) with Two Chairs
  • Number of Exhibitor Badges: 2
  • Complimentary meals (available with exhibitor badge)
  • Exhibit Location: Designated Location

Deadline for order commitment is 10/31/2025 12:00:00 AM.

Exhibitor Package - Silver Level Price: $5000.00
Includes:
  • Recognition as a Silver Level Exhibitor
  • 6ft. Tabletop Display (Draped) with Two Chairs
  • Number of Exhibitor Badges: 3
  • Complimentary meals (available with exhibitor badge)
  • Exhibit Location: Designated Location

Deadline for order commitment is 10/31/2025 12:00:00 AM.

Exhibitor Package - Gold Level Price: $7500.00
Includes:
  • Recognition as a Gold Level Exhibitor
  • 6ft. Tabletop Display (Draped) with Two Chairs
  • Number of Exhibitor Badges: 4
  • Complimentary meals (available with exhibitor badge)
  • Exhibit Location: Designated Premium Location

Deadline for order commitment is 10/31/2025 12:00:00 AM.

Exhibitor Package - Platinum Level Price: $10000.00
Includes:
  • Recognition as a Platinum Level Exhibitor
  • 6ft. Tabletop Display (Draped) with Two Chairs
  • Number of Exhibitor Badges: 5
  • Complimentary meals (available with exhibitor badge)
  • Exhibit Location: Designated Premium Location

Deadline for order commitment is 10/31/2025 12:00:00 AM.

Exhibitor Package - 1 - Additional Badge Price: $500.00
Includes:
  • Recognition as a 1 - Additional Badge Exhibitor
  • Number of Exhibitor Badges: 1

Deadline for order commitment is 11/7/2025 12:00:00 AM.

Exhibitor Package - 2 - Additional Badges Price: $1000.00
Includes:
  • Recognition as a 2 - Additional Badges Exhibitor
  • Number of Exhibitor Badges: 2

Deadline for order commitment is 11/7/2025 12:00:00 AM.

Exhibitor Package - 3 - Additional Badges Price: $1500.00
Includes:
  • Recognition as a 3 - Additional Badges Exhibitor
  • Number of Exhibitor Badges: 3

Deadline for order commitment is 11/7/2025 12:00:00 AM.

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2023 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram